Occidental Petroleum Corporation (NYSE:OXY): Credit Suisse said recent Occidental weakness provides a buying opportunity given management commentary regarding growth, outlook in the Permian and California, and slowing Upstream capital expenditures. Shares are Outperform rated with a $135 price target.
Pandora Media Inc (NYSE:P): William Blair notes that Pandora increased its radio market share to 5.95% in Q1, up from 5.55% last quarter, and that the company continues to take market share within the Internet radio market. The firm continues to recommend purchase of the stock following Pandora’s Q1 results and increased guidance.
Xueda Education Group American (NYSE:XUE): William Blair believes Xueda Education’s Q1 results were solid and views current share levels as attractive for new money. The firm maintains an Outperform rating on the name.
Johnson & Johnson (NYSE:JNJ): Leerink believes the FDA panel vote against approval of Johnson & Johnson’s (NYSE:JNJ) and Bayer’s (BAYRY) Xarelto for the prevention of CV events in patients with a recent acute coronary syndrome will likely delay approval by 3-12 months, not kill the drug for this indication. The firm believes Bristol-Myers’ (NYSE:BMY) and Pfizer’s (NYSE:PFE) Eliquis could benefit slightly from a Xarelto delay.
SAIC, Inc. (NYSE:SAI): Jefferies thinks sentiment on shares of SAIC is worse than the company’s fundamentals into the Q1 results on May 31. The firm believes SAIC’s FY13 guidance remains safe and that shares are very attractively valued at current levels.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.